This HTML5 document contains 107 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
schemahttp://schema.org/
rdfshttp://www.w3.org/2000/01/rdf-schema#
skoshttp://www.w3.org/2004/02/skos/core#
n5http://dx.doi.org/10.1093/
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n11http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q54251449
rdf:type
wikibase:Item
schema:description
1993年學術文章 1993年学术文章 научни чланак articolo scientifico artikulong pang-agham teaduslik artikkel artigo científico (publicado na 1993) vitenskapelig artikkel სამეცნიერო სტატია naučni članak գիտական հոդված мақолаи илмӣ سائنسی مضمون מאמר מדעי 1993年の論文 научна статия επιστημονικό άρθρο 1993年學術文章 مقالهٔ علمی wissenschaftlicher Artikel videnskabelig artikel (udgivet 1993) vedecký článok 1993年学术文章 мақолаи илмӣ vetenskaplig artikel vitskapeleg artikkel наукова стаття, опублікована в січні 1993 1993年學術文章 artículu científicu bài báo khoa học научни чланак tudományos cikk artikull shkencor artículo científico publicado en 1993 articol științific 1993년 논문 wetenschappelijk artikel artykuł naukowy 1993年學術文章 مقالة علمية tieteellinen artikkeli artigo científico 1993年學術文章 1993年学术文章 artigo científico (publicado na 1993) บทความทางวิทยาศาสตร์ bilimsel makale scientific article научная статья mokslinis straipsnis 1993年學術文章 article scientifique (publié 1993) article scientific ১৯৯৩-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ 1993年学术文章 scienca artikolo 1993年学术文章 article científic vědecký článek 1993 nî lūn-bûn
p:P577
wds:Q54251449-D7ADF18A-9392-45A5-92FF-95EC58F570EC
wdt:P577
1993-01-01T00:00:00Z
p:P2093
wds:Q54251449-E36BF29F-8D63-4C49-A836-49238701E945 wds:Q54251449-CC235848-D026-4D0A-BD4A-A4328A031885 wds:Q54251449-8E612519-3F82-4E05-A732-1EBCED4DA51A wds:Q54251449-5F5B5171-9786-448D-9202-D1C547611BE8 wds:Q54251449-7110B171-C154-4B90-97CE-780E2BB0DB0B wds:Q54251449-5960F10D-2A2B-4DA6-85A5-B74C2A73724D wds:Q54251449-3A351D52-F4E3-464A-B63F-DE55616829EE wds:Q54251449-40CDB022-00BA-42E6-A42D-D9A1975CA33F
wdt:P2093
W Jonat D K Hossfeld L Edler E Heidemann M Goebel C Bohn K Mross W Queisser
rdfs:label
Randomized phase II study of single-agent epirubicin +/- verapamil in patients with advanced metastatic breast cancer. An AIO clinical trial. Arbeitsgemeinschaft Internistische Onkologie of the German Cancer Society. Randomized phase II study of single-agent epirubicin +/- verapamil in patients with advanced metastatic breast cancer. An AIO clinical trial. Arbeitsgemeinschaft Internistische Onkologie of the German Cancer Society.
skos:prefLabel
Randomized phase II study of single-agent epirubicin +/- verapamil in patients with advanced metastatic breast cancer. An AIO clinical trial. Arbeitsgemeinschaft Internistische Onkologie of the German Cancer Society. Randomized phase II study of single-agent epirubicin +/- verapamil in patients with advanced metastatic breast cancer. An AIO clinical trial. Arbeitsgemeinschaft Internistische Onkologie of the German Cancer Society.
schema:name
Randomized phase II study of single-agent epirubicin +/- verapamil in patients with advanced metastatic breast cancer. An AIO clinical trial. Arbeitsgemeinschaft Internistische Onkologie of the German Cancer Society. Randomized phase II study of single-agent epirubicin +/- verapamil in patients with advanced metastatic breast cancer. An AIO clinical trial. Arbeitsgemeinschaft Internistische Onkologie of the German Cancer Society.
p:P1476
wds:Q54251449-BCD16CDA-A3E3-4EC8-B3AE-18CC02569B48
wdt:P1476
Randomized phase II study of single-agent epirubicin +/- verapamil in patients with advanced metastatic breast cancer. An AIO clinical trial. Arbeitsgemeinschaft Internistische Onkologie of the German Cancer Society.
p:P304
wds:Q54251449-F85139BB-074D-4E04-A2DE-E132EF83F86B
wdt:P304
45-50
p:P31
wds:Q54251449-2408296F-77FE-4D35-8FE1-4FA7926C994A
wdt:P31
wd:Q13442814
p:P921
wds:Q54251449-101E4EA0-98BF-4818-A72B-A7664400E2EF wds:Q54251449-2D7EC1E6-A782-41F9-A1AD-016F88CA55AF
wdt:P921
wd:Q42824440 wd:Q410291
p:P698
wds:Q54251449-2BD7053E-8932-4F47-998F-11674E89B625
wdtn:P698
n11:8435362
wdt:P698
8435362
p:P1433
wds:Q54251449-493EB76D-472E-4085-AF11-904EEB5FD47E
wdt:P1433
wd:Q326122
p:P433
wds:Q54251449-71AFDCC7-212B-4E20-94DD-B0BA52FEA7AA
p:P478
wds:Q54251449-AE36AB26-2C78-4D2F-8C7F-D272AB61E4B6
wdt:P433
1
wdt:P478
4
p:P356
wds:Q54251449-2BBCB70B-525C-421F-830B-648FBD960E3E
wdtn:P356
n5:OXFORDJOURNALS.ANNONC.A058356
wdt:P356
10.1093/OXFORDJOURNALS.ANNONC.A058356